Int J Arrhythm.  2024 Dec;25(4):18. 10.1186/s42444-024-00127-4.

Machine learning‑based prediction of new onset of atrial fibrillation after mitral valve surgery

Abstract

Background
New-onset postoperative atrial fibrillation (nPOAF) is a common complication after cardiac surgery (30– 50%), being associated with unfavorable long-term outcomes. Using the Society of Thoracic Surgeons National Adult Cardiac Database, we used machine learning (ML) to predict nPOAF and related 30-day outcomes following mitral valve (MV) surgery. A total of 27,856 MV operations were performed at 910 centers between 7/1/2017 and 6/30/2020 on patients without AF or a prior permanent pacemaker. The primary endpoint was nPOAF postoperatively. ML tech‑ niques utilized included penalized logistic regression, gradient boosting, decision trees, and random forests.
Results
The overall incidence of nPOAF was 35.4% and that of new pacemaker insertion was 5.6%. Patients who developed nPOAF were older (67 ± 10 vs 60 ± 13 years), had more mitral valve stenosis (14.1% vs 11.7%), and hyperten‑ sion (72.1% vs 63.3%). They underwent more mitral valve replacement (39.1% vs 32.7%) and coronary artery bypass grafting (23.9% vs 16%). For predicting nPOAF, ML methods offer sensitivity, specificity and precision superior to logis‑ tic regression. The accuracy rate was identical with penalized and non-penalized logistic regression (0.672).
Conclusions
Predicting nPOAF and its short-term sequelae following MV surgery remains highly challenging. Machine learning methods offer a moderate degree of improvement in predicting nPOAF even in large national-level studies, in the absence of multi-modal data, such as real-time wearables data, electrocardiograms, heart rhythm moni‑ toring, or cardiac imaging.

Keyword

Atrial fibrillation; Machine learning; Postoperative; Heart rhythm monitoring; Outcome prediction; Cardiac
Full Text Links
  • IJA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr